Similar results were obtained in another single-cell transcriptomic study, which demonstrated that cells that express either IL-17A or IL-17F are expanded even in early HS lesions, and IL-17F-producing cells can co-localize with IL-1-expressing cells in chronic lesions. This evidence concerns the gene IL1B and histiocytic sarcoma.